XML 158 R135.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-Based Compensation (Details) - Schedule of Stock Option Activity - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2023
Schedule Of Stock Option Activity Abstract    
Number of Shares, Granted   2,284,000
Average Exercise Price per Share, Granted   $ 0.97
Aggregate Intrinsic Value, Granted [1]  
Weighted Average Remaining Contractual Term in Years, Granted   5 years 9 months 18 days
Number of Shares, Exercised  
Average Exercise Price per Share, Exercised  
Aggregate Intrinsic Value, Exercised [1]  
Number of Shares, Forfeited   (70,000)
Average Exercise Price per Share, Forfeited   $ 0.98
Aggregate Intrinsic Value, Forfeited [1]  
Weighted Average Remaining Contractual Term in Years, Forfeited   5 years 9 months 18 days
Number of Shares, Outstanding ending balance 1,650,086 3,864,086
Average Exercise Price per Share, Outstanding ending balance $ 1.96 $ 1.39
Aggregate Intrinsic Value, Outstanding ending balance [1]
Weighted Average Remaining Contractual Term in Years, Outstanding ending balance 4 years 8 months 12 days 4 years 3 months 18 days
Number of Shares, Exercisable ending Balance 549,958 549,958
Average Exercise Price per Share, Exercisable ending Balance $ 1.96 $ 1.96
Aggregate Intrinsic Value, Exercisable ending Balance [1]
Weighted Average Remaining Contractual Term in Years, Exercisable ending Balance, 4 years 8 months 12 days 3 years 8 months 12 days
[1] The intrinsic value of the stock options at December 31, 2023 is the amount by which the market value of the Company’s common stock of $1.05 as of December 31, 2023 exceeds the average exercise price of the option. As of December 31, 2023, the intrinsic value of the outstanding and exercisable stock options was $nil.